Saltar al contenido
Merck

Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.

Bioorganic & medicinal chemistry letters (2005-12-08)
Torsten Hoffmann, Michael Bös, Heinz Stadler, Patrick Schnider, Walter Hunkeler, Thierry Godel, Guido Galley, Theresa M Ballard, Guy A Higgins, Sonia M Poli, Andrew J Sleight
RESUMEN

The discovery of a novel, achiral pyridine class of potent and orally active neurokinin-1 (NK(1)) receptor antagonists is described. The evaluation of this class is briefly outlined, leading to the identification of netupitant 21 and befetupitant 29, two new proprietary chemical entities with high affinity and excellent CNS penetration.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Netupitant, ≥98% (HPLC)